Harnessing Endogenous Metabolic Modulators to Target Multiple Disease Pathways in NASH

Time: 3:00 pm
day: Day One


  • Monitoring disease progression and therapeutic efficacy with non-invasive biomarkers in clinical studies
  • Reversing NASH through targeting multiple pathways
  • Managing diverse patient populations and investigating clinical data: with and without type 2 diabetes and navigating pediatric studies